KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Divestments (2021 - 2025)

Biogen has reported Divestments over the past 7 years, most recently at $56.7 million for Q4 2025.

For Q4 2025, Divestments rose 121.63% year-over-year to $56.7 million; the TTM value through Dec 2025 reached -$205.4 million, up 77.93%, while the annual FY2025 figure was $56.7 million, 60.82% down from the prior year.
Divestments for Q4 2025 was $56.7 million at Biogen, up from -$262.1 million in the prior quarter.
Over five years, Divestments peaked at $990.3 million in Q2 2022 and troughed at -$990.3 million in Q4 2022.
A 5-year average of -$86.7 million and a median of $28.1 million in 2021 define the central range for Divestments.
On a YoY basis, Divestments climbed as much as 3624.2% in 2022 and fell as far as 1614.22% in 2022.
Year by year, Divestments stood at $65.4 million in 2021, then tumbled by 1614.22% to -$990.3 million in 2022, then surged by 32.5% to -$668.5 million in 2023, then surged by 60.79% to -$262.1 million in 2024, then soared by 121.63% to $56.7 million in 2025.
Business Quant data shows Divestments for BIIB at $56.7 million in Q4 2025, -$262.1 million in Q4 2024, and -$668.5 million in Q4 2023.